Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
| - | HB14-1283 makes the following several modifications to the electronic prescription drug monitoring program including: • The dissemination of automatic reports to prescribers and pharmacies when a patient meets a defined threshold that takes into account the number of prescribers and pharmacies visited within a certain timeframe. Reports will start in September 2014. • Allows a prescribing practitioner or a pharmacist to delegate authority to access the database to up to 3 designees acting for the practitioner or pharmacist, and requires each designee to register with the program under a sub-account of the practitioner or pharmacist. Delegated Access will start in January 2015. • Requires prescribing practitioners and pharmacists to register and create user accounts with the program by a deadline established by the Director of the Division of Professions and Occupations.Those deadlines are: • Pharmacists and DEA-registered Advanced Practice Nurses: September 30, 2014 • DEA-registered Dentists, Veterinarians, Optometrists and Podiatrists: October 31, 2014 • DEA-registered Medical Board licensees: November 30, 2014 • Allows the Colorado Department of Public Health and Environment (CDPHE) to access data from the PDMP for public health research. CDPHE access will begin in the Fall 2014. • Allows an out-of-state pharmacist to obtain Colorado PDMP data in connection with a current patient to whom the pharmacist is dispensing a controlled substance or is providing clinical patient care services. This ability to obtain such data is already available. • Adds individual pharmacies as an eligible subject for information requests by law enforcement officials if the request for information is accompanied by a court order or subpoena beginning immediately. • Allows federally owned and operated pharmacies to submit data to the database beginning immediately. • Authorizes the executive director of the department of regulatory agencies to create a prescription drug monitoring program task force, or to request assistance from the team assembled by the governor's office to develop a plan to reduce prescription drug abuse, to study the program and make recommendations to the executive director on ways to ensure that the program is effective at reducing prescription drug abuse and misuse. The Executive Director has requested the Governor’s Consortium for Prescription Drug Abuse serve as the taskforce. Together, these modifications to the PDMP will require updating the online PDMP system and notifying prescribers and dispensers as well as those who receive delegated access to the PDMP of the provisions of this bill. |
| - | HB14-1083 Acute treatment units (ATU) provide medically supervised behavioral health treatment services to individuals who suffer from psychiatric disorders. Current law does not allow an ATU to have an onsite stock of medications. The bill allows an ATU to procure, store, order, dispense, and administer prescription medications and to receive a supply of emergency kits or starter doses from a registered prescription drug outlet or licensed hospital for patient treatment. Implementation of this bill will require rulemaking by the State Board of Pharmacy, the updating of applications and outreach. Rulemaking will occur on August 21, 2014. |
| - | HB14-1290 adds to the definition of "other outlet" under the statutes governing the practice of pharmacy a telepharmacy outlet located more than 20 miles from the nearest pharmacy. A prescribing practitioner cannot own a telepharmacy, and the State Board of Pharmacy is authorized to impose additional telepharmacy ownership restrictions by rule. Implementation of this bill will require rulemaking by the State Board of Pharmacy and the updating of applications. It is anticipated there will be a very small number of telepharmacy registering as an “other outlet.” |
| - | SB14-095 Under previous law, a prescription drug outlet could only distribute compounded drugs for office use to practitioners who are authorized to prescribe drugs. The bill allows a prescription drug outlet to also distribute compounded drugs to a hospital located in Colorado. |
No comments:
Post a Comment